Christian Marth

34.3k total citations · 3 hit papers
411 papers, 14.0k citations indexed

About

Christian Marth is a scholar working on Oncology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Christian Marth has authored 411 papers receiving a total of 14.0k indexed citations (citations by other indexed papers that have themselves been cited), including 170 papers in Oncology, 151 papers in Reproductive Medicine and 97 papers in Molecular Biology. Recurrent topics in Christian Marth's work include Ovarian cancer diagnosis and treatment (146 papers), Endometrial and Cervical Cancer Treatments (63 papers) and Estrogen and related hormone effects (44 papers). Christian Marth is often cited by papers focused on Ovarian cancer diagnosis and treatment (146 papers), Endometrial and Cervical Cancer Treatments (63 papers) and Estrogen and related hormone effects (44 papers). Christian Marth collaborates with scholars based in Austria, Germany and United States. Christian Marth's co-authors include Alain G. Zeimet, Heidi Fiegl, Martin Widschwendter, Elisabeth Müller‐Holzner, G. Daxenbichler, Elisabeth Mueller‐Holzner, Hannes Müller, Andreas Widschwendter, Hans H. Goebel and Peter W. Laird and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Blood.

In The Last Decade

Christian Marth

399 papers receiving 13.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epigenetic stem cell signature in cancer

2006 775 citations Martin Widschwendter, Heidi Fiegl et al. profile →
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer

2015 558 citations Nicoletta Colombo, Antonio González-Martı́n et al. International Journal of Gynecological Cancer profile →
Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

2022 304 citations Ana Oaknin, Philipp Harter et al. Annals of Oncology profile →

Peers

Countries citing papers authored by Christian Marth

Since Specialization

Citations

This map shows the geographic impact of Christian Marth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christian Marth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christian Marth more than expected).

Fields of papers citing papers by Christian Marth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christian Marth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christian Marth. The network helps show where Christian Marth may publish in the future.

Co-authorship network of co-authors of Christian Marth

This figure shows the co-authorship network connecting the top 25 collaborators of Christian Marth. A scholar is included among the top collaborators of Christian Marth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christian Marth. Christian Marth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TroFuse-020/GOG-3101/ENGOT-Cx20: A Phase 3, Randomised, Active-Controlled, Open-Label, Multicentre Study Comparing Sacituzumab Tirumotecan Monotherapy Vs Treatment Of Physician’s Choice As Second-Line Treatment For Recurrent Or Metastatic Cervical Cancer 2025 ·International Journal of Gynecological Cancer ·(unknown), Kristina Lindemann, Zhongqiu Lin, Shin Nishio, Ana Oaknin, Jean‐Emmanuel Kurtz, Giorgio Valabrega, M. Valeria Cáceres, Philipp Harter, Lucy Gilbert, Azmat Sadozye, (unknown), Toon Van Gorp, Ingrid Boere, Christian Marth, Linda Duska, Bradley J. Monk, (unknown), Cumhur Tekin, Mansoor Raza Mirza	1
2	A randomized, double-blind, phase II study of MK-4280A (coformulation of favezelimab and pembrolizumab) plus lenvatinib versus pembrolizumab plus lenvatinib among patients with previously-treated mismatch repair proficient advanced endometrial cancer 2024 ·Gynecologic Oncology ·Eugenia Girda, Vicky Makker, Christian Marth, Toon Van Gorp, Mansoor Raza Mirza, (unknown), (unknown), Roman Groisberg, Fan Jin, David M. O’Malley	1
3	Pegylated liposomal doxorubicin combined with trabectedin as a treatment option in uterine sarcomas: a single-institution retrospective analysis 2024 ·International Journal of Gynecological Cancer ·(unknown), (unknown), Katharina Leitner, (unknown), (unknown), Christian Marth, Alain G. Zeimet	0
4	737P Characterization of tumor response with lenvatinib plus pembrolizumab (LEN + Pembro) in the ENGOT-en9/LEAP-001 study 2024 ·Annals of Oncology ·Anna Dańska-Bidzińska, (unknown), Vanda Salutari, Ali̇ Ayhan, Ignacio A. Romero, Tally Levy, (unknown), J.F. Baurain, Paweł Mach, (unknown), Helen Mackay, (unknown), (unknown), Brian M. Slomovitz, David S. Miller, Jodi A. McKenzie, Lan Yao, Vivek Khemka, Angélica Nogueira‐Rodrigues, Christian Marth	1
5	An angiogenic tumor phenotype predicts poor prognosis in ovarian cancer 2023 ·Gynecologic Oncology ·Verena Wieser, Irina Tsibulak, Daniel Reimer, Alain G. Zeimet, Heidi Fiegl, Hubert Hackl, Christian Marth	9
6	#1120 Durvalumab with paclitaxel/carboplatin + bevacizumab then maintenance durvalumab, bevacizumab + olaparib in patients with newly diagnosed advanced ovarian cancer without a tumour BRCA1/2 mutation: results from the DUO-O/ENGOT-Ov46/AGO-OVAR 23/GOG-3025 trial 2023 ·VBN Forskningsportal (Aalborg Universitet) ·Christian Marth, Tjoung‐Won Park‐Simon, Carol Aghajanian, Alexander Reuß, Shin Nishio, Myong Cheol Lim, María Jesús Rubio-Pérez, Mehmet Ali Vardar, Giovanni Scambia, Renaud Sabatier, Charlotte Aaquist Haslund, Nicoletta Colombo, Anita Chudecka-Głaz, Stéphanie Lheureux, (unknown), Fabienne Schochter, Robert M. Wenham, Aikou Okamoto, Emily Day, Philipp Harter	2
7	Real-world outcomes and healthcare resource utilization in recurrent or advanced endometrial cancer patients rechallenged with platinum chemotherapy in Europe (062) 2023 ·Gynecologic Oncology ·Christian Marth, Vimalanand S. Prabhu, Sneha S. Kelkar, Jingchuan Zhang, (unknown)	1
8	#528 Efficacy of subsequent chemotherapy followed by PARP inhibitor maintenance in patients with advanced ovarian cancer in the phase III PAOLA-1/ENGOT-Ov25 trial 2023 ·Christian Marth, Marie‐Ange Mouret‐Reynier, Domenica Lorusso, Claire Cropet, Philipp Harter, Eva Guerra, Takashi Matsumoto, Ignace Vergote, Nicoletta Colombo, Johanna Mäenpää, Coriolan Lebreton, Nikolaus de Gregorio, Anna Maria Mosconi, María Jesús Rubio, Hugues Bourgeois, Peter A. Fasching, Anne‐Claire Hardy‐Bessard, Dominik Denschlag, Éric Pujade-Lauraine, Isabelle Ray‐Coquard	7
9	Surgery and HIPEC in relapse for all patients with ovarian cancer? 2023 ·ESMO Open ·Shira Peleg Hasson, Isabelle Ray‐Coquard, Christian Marth, Philipp Harter	1
10	2022-RA-702-ESGO Real-world treatment patterns and outcomes in recurrent or advanced endometrial cancer patients initiating 1st-line systemic therapy in Europe: a retrospective chart review study 2022 ·International Journal of Gynecological Cancer ·Vimalanand S. Prabhu, Sneha S. Kelkar, Jingchuan Zhang, (unknown), (unknown), Christian Marth	1
11	EPIK-O/ENGOT-OV61: Alpelisib Plus Olaparib vs Cytotoxic Chemotherapy in High-Grade Serous Ovarian Cancer (Phase III Study) 2022 ·Future Oncology ·Panagiotis A. Konstantinopoulos, Antonio González-Martı́n, Felipe Melo Cruz, Michael Friedländer, Rosalind Glasspool, Domenica Lorusso, Christian Marth, Bradley J. Monk, Jae‐Weon Kim, (unknown), (unknown), (unknown), (unknown), Ursula A. Matulonis	16
12	European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma 2021 ·International Journal of Gynecological Cancer ·Nicole Concin, François Planchamp, Nadeem R. Abu‐Rustum, Beyhan Ataseven, David Cibula, Anna Fagotti, Christina Fotopoulou, Paweł Knapp, Christian Marth, Philippe Morice, Denis Querleu, Jalid Sehouli, Artem Stepanyan, Çağatay Taşkıran, Ignace Vergote, Pauline Wimberger, Ignacio Zapardiel, Jan Persson	20
13	E2F3a Is Critically Involved in Epidermal Growth Factor Receptor–Directed Proliferation in Ovarian Cancer 2010 ·Cancer Research ·Daniel Reimer, Michael Hubalek, Svenja Riedle, Sergej Skvortsov, Martin Erdel, Nicole Concin, Heidi Fiegl, Elisabeth Müller‐Holzner, Christian Marth, Karl Illmensee, Peter Altevogt, Alain G. Zeimet	30
14	アジュバント内分泌療法へのゾレドロン酸(ZOL)追加はホルモン応答性早期乳房腫瘍(HREBC)の閉経前女性の無病生存(DF)及び非再発生存(RFS)を改善する:オーストリア乳房腫瘍及び結腸直腸腫瘍研究グループ12(ABCSG-12)試験の多変量解析 2009 ·Annals of Oncology ·Michael Gnant, (unknown), Walter Schippinger, G. Luschin-Ebengreuth, (unknown), C Menzel, R. Jakesz, E. Kubista, Christian Marth, (unknown)	1
15	Results of the 2006 Innsbruck International Consensus Conference on intraperitoneal chemotherapy in patients with ovarian cancer 2007 ·Cancer ·Christian Marth, Joan L. Walker, Richard R. Barakat, Antonio Casado, Angiolo Gadducci, Brigitte Miller, Franco Odicino, Eric Pujade‐Lauraine, Jalid Sehouli, Claes G. Tropé, Lari Wenzel, Alain G. Zeimet	23
16	Circulating Tumor-Specific DNA: A Marker for Monitoring Efficacy of Adjuvant Therapy in Cancer Patients 2005 ·Cancer Research ·Heidi Fiegl, Simone Millinger, Elisabeth Mueller‐Holzner, Christian Marth, Christian Ensinger, Andreas Berger, Helmut Klocker, Hans H. Goebel, Martin Widschwendter	208
17	Association of Breast Cancer DNA Methylation Profiles with Hormone Receptor Status and Response to Tamoxifen 2004 ·Cancer Research ·Martin Widschwendter, Kimberly D. Siegmund, Hannes Müller, Heidi Fiegl, Christian Marth, Elisabeth Müller‐Holzner, Peter A. Jones, Peter W. Laird	268
18	DNA Methylation in Serum and Tumors of Cervical Cancer Patients 2004 ·Clinical Cancer Research ·Andreas Widschwendter, Hannes Müller, Heidi Fiegl, Lennart Ivarsson, Annemarie Wiedemair, Elisabeth Müller‐Holzner, Hans H. Goebel, Christian Marth, Martin Widschwendter	100
19	DNA Hypomethylation and Ovarian Cancer Biology 2004 ·Cancer Research ·Martin Widschwendter, Guanchao Jiang, Christian B. Woods, Hannes Müller, Heidi Fiegl, Hans H. Goebel, Christian Marth, Elisabeth Müller‐Holzner, Alain G. Zeimet, Peter W. Laird, Melanie Ehrlich	186
20	Suppressive Effects of Neopterin on Inducible Nitric Oxide Synthase Gene Expression in Ovarian Carcinoma Cells in vitro 2001 ·Pteridines ·Josef Rieder, Anton Amann, (unknown), (unknown), Markus J. Seibel, Christian Marth, Georg Hoffmann	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact